ArticleScientific reports2019

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X.

Lorena Favaro Pavon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.